These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

168 related articles for article (PubMed ID: 31289483)

  • 1. MicroRNA-200c reverses drug resistance of human gastric cancer cells by targeting regulation of the NER-ERCC3/4 pathway.
    Li M; Gao M; Xie X; Zhang Y; Ning J; Liu P; Gu K
    Oncol Lett; 2019 Jul; 18(1):145-152. PubMed ID: 31289483
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MiR-192-5p reverses cisplatin resistance by targeting ERCC3 and ERCC4 in SGC7901/DDP cells.
    Xie X; Huang N; Zhang Y; Wei X; Gao M; Li M; Ning J; Liu W; Zhao Q; Wang H; Gu K
    J Cancer; 2019; 10(4):1039-1051. PubMed ID: 30854110
    [TBL] [Abstract][Full Text] [Related]  

  • 3. miR‑138‑5p modulates the expression of excision repair cross‑complementing proteins ERCC1 and ERCC4, and regulates the sensitivity of gastric cancer cells to cisplatin.
    Ning J; Jiao Y; Xie X; Deng X; Zhang Y; Yang Y; Zhao C; Wang H; Gu K
    Oncol Rep; 2019 Feb; 41(2):1131-1139. PubMed ID: 30535472
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-187 influences cisplatin-resistance of gastric cancer cells through regulating the TGF-β/Smad signaling pathway.
    Zhu QL; Li Z; Lv CM; Wang W
    Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9907-9914. PubMed ID: 31799659
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MicroRNA-362-5p enhances the cisplatin sensitivity of gastric cancer cells by targeting suppressor of zeste 12 protein.
    Wei X; Gao M; Ahmed Y; Gao M; Liu W; Zhang Y; Xie X; Zhao Q; Wang H; Gu K
    Oncol Lett; 2019 Aug; 18(2):1607-1616. PubMed ID: 31423228
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MicroRNA-200c regulates cisplatin resistance by targeting ZEB2 in human gastric cancer cells.
    Jiang T; Dong P; Li L; Ma X; Xu P; Zhu H; Wang Y; Yang B; Liu K; Liu J; Xue J; Lv R; Su P; Kong G; Chang Y; Zhao C; Wang L
    Oncol Rep; 2017 Jul; 38(1):151-158. PubMed ID: 28534959
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibitory effects of miRNA-200c on chemotherapy-resistance and cell proliferation of gastric cancer SGC7901/DDP cells.
    Chen Y; Zuo J; Liu Y; Gao H; Liu W
    Chin J Cancer; 2010 Dec; 29(12):1006-11. PubMed ID: 21114921
    [TBL] [Abstract][Full Text] [Related]  

  • 8. MicroRNA-200c regulates the sensitivity of chemotherapy of gastric cancer SGC7901/DDP cells by directly targeting RhoE.
    Chang L; Guo F; Wang Y; Lv Y; Huo B; Wang L; Liu W
    Pathol Oncol Res; 2014 Jan; 20(1):93-8. PubMed ID: 23821457
    [TBL] [Abstract][Full Text] [Related]  

  • 9. miR-149 reverses cisplatin resistance of gastric cancer SGC7901/DDP cells by targeting FoxM1.
    Li X; Liang J; Liu YX; Wang Y; Yang XH; Luan BH; Zhang GL; Du J; Wu XH
    Pharmazie; 2016 Nov; 71(11):640-643. PubMed ID: 29441968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-574-3p regulates epithelial mesenchymal transition and cisplatin resistance via targeting ZEB1 in human gastric carcinoma cells.
    Wang M; Zhang R; Zhang S; Xu R; Yang Q
    Gene; 2019 Jun; 700():110-119. PubMed ID: 30917930
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Upregulation of microRNA-375 increases the cisplatin-sensitivity of human gastric cancer cells by regulating ERBB2.
    Zhou N; Qu Y; Xu C; Tang Y
    Exp Ther Med; 2016 Feb; 11(2):625-630. PubMed ID: 26893657
    [TBL] [Abstract][Full Text] [Related]  

  • 12. MicroRNA-218 enhances gastric cancer cell cisplatin sensitivity by targeting survivin.
    Zhang Z; Kong Y; Yang W; Zhang B; Ma F; Liu H; Hua Y
    Exp Ther Med; 2018 Dec; 16(6):4796-4802. PubMed ID: 30542435
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Downregulation of microRNA-17-5p inhibits drug resistance of gastric cancer cells partially through targeting p21.
    Wang Z; Ji F
    Oncol Lett; 2018 Apr; 15(4):4585-4591. PubMed ID: 29541229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Upregulation of microRNA-34a enhances the DDP sensitivity of gastric cancer cells by modulating proliferation and apoptosis via targeting MET.
    Zhang Z; Kong Y; Yang W; Ma F; Zhang Y; Ji S; Ma EM; Liu H; Chen Y; Hua Y
    Oncol Rep; 2016 Oct; 36(4):2391-7. PubMed ID: 27513895
    [TBL] [Abstract][Full Text] [Related]  

  • 15. MiR-503 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R and BCL2.
    Wang T; Ge G; Ding Y; Zhou X; Huang Z; Zhu W; Shu Y; Liu P
    Chin Med J (Engl); 2014; 127(12):2357-62. PubMed ID: 24931256
    [TBL] [Abstract][Full Text] [Related]  

  • 16. MicroRNA-206 facilitates gastric cancer cell apoptosis and suppresses cisplatin resistance by targeting MAPK2 signaling pathway.
    Chen Z; Gao YJ; Hou RZ; Ding DY; Song DF; Wang DY; Feng Y
    Eur Rev Med Pharmacol Sci; 2019 Jan; 23(1):171-180. PubMed ID: 30657558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inhibition of c-Myc by let-7b mimic reverses mutidrug resistance in gastric cancer cells.
    Yang X; Cai H; Liang Y; Chen L; Wang X; Si R; Qu K; Jiang Z; Ma B; Miao C; Li J; Wang B; Gao P
    Oncol Rep; 2015 Apr; 33(4):1723-30. PubMed ID: 25633261
    [TBL] [Abstract][Full Text] [Related]  

  • 18. miR-1271 regulates cisplatin resistance of human gastric cancer cell lines by targeting IGF1R, IRS1, mTOR, and BCL2.
    Yang M; Shan X; Zhou X; Qiu T; Zhu W; Ding Y; Shu Y; Liu P
    Anticancer Agents Med Chem; 2014; 14(6):884-91. PubMed ID: 24875127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Let-7b attenuates cisplatin resistance and tumor growth in gastric cancer by targeting AURKB.
    Han X; Zhang JJ; Han ZQ; Zhang HB; Wang ZA
    Cancer Gene Ther; 2018 Dec; 25(11-12):300-308. PubMed ID: 30237418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Molecular mechanism of cisplatin to enhance the ability of TRAIL in reversing multidrug resistance in gastric cancer cells].
    Zhu X; Zhang K; Wang Q; Chen S; Gou Y; Cui Y; Li Q
    Zhonghua Zhong Liu Za Zhi; 2015 Jun; 37(6):404-11. PubMed ID: 26463141
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.